Bolt Biotherapeutics (BOLT) Financials

$3.90

$0.01 (0.13%)

As on 04-Sep-2026 16:00EDT

Market cap

$8 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.70	7.70	7.69	7.88	5.73	1.26
Cost of Revenue	0.75	1.49	2.18	61.54	73.12	75.66
Gross Profit	4.50	6.20	7.69	-53.67	-67.39	-74.40
Operating Expenses	33.78	40.84	80.74	22.53	22.93	18.39
Operating Profit (EBIT)	-29.28	-34.63	-73.05	-76.20	-90.32	-92.79
Other Income	--	--	--	--	--	--
Profit before Tax	-28.74	-33.38	-63.12	-69.20	-88.10	-98.59
Provision for Tax	--	--	--	1.72	-2.22	5.80
Profit after Tax (Net Income)	-28.74	-33.38	-63.12	-69.20	-88.10	-98.59
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-88.10	-98.59

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	12.64	26.51	57.20	112.74	171.51	250.12
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	19.84	21.81	26.58	26.59	33.18	36.27
Current Liabilities	7.87	8.44	15.86	20.46	23.12	21.33
Total Liabilities	48.21	56.75	99.63	159.78	227.81	307.72

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	19.78	26.49	48.82	54.08	55.06	118.56
Current Assets	20.56	30.26	50.81	105.71	172.75	189.16
Total Assets	48.21	56.75	99.63	159.78	227.81	307.72
Total Debt*	21.62	22.96	25.21	20.22	22.61	24.36
Net Current Assets	12.70	21.83	34.96	85.25	149.63	167.83

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-39.85	-61.29	-69.53	-76.50	-57.07
Cash Flow from Investing Activities	--	44.30	57.58	71.04	57.86	-232.20
Cash from Financing Activities	--	0.02	0.11	0.25	0.50	311.11
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-15.71	-17.85	-32.97	-36.48	-46.92	-52.91
Cash EPS ($)	-16.53	-17.16	-32.04	-35.50	-46.03	-52.27
Adjusted Book Value ($)	6.56	14.17	29.88	59.43	91.34	134.22
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-21.31	-32.02	-36.65	-40.75	-30.62
Free Cash Flow per Share ($)	--	-21.35	-32.04	-36.76	-41.79	-31.88

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-50.62	-58.61	-42.31	-37.60	-109.30
ROE (%)	-146.83	-79.75	-74.28	-48.69	-41.79	-135.83
ROA (%)	-42.26	-42.69	-48.66	-35.71	-32.90	-55.66
EBIT Margin (%)	-611.47	-433.74	-887.33	-878.58	-1,537.76	-7,824.68
Net Margin (%)	-611.47	-433.74	-820.78	-878.58	-1,537.76	-7,824.68
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-83.37	0.00	-0.02	0.37	3.55	4.45
EBIT Growth (%)	43.33	51.09	1.39	21.45	10.64	-100.46
Net Profit Growth (%)	43.33	47.12	8.79	21.45	10.64	-62.35
EPS Growth (%)	40.68	0.46	0.10	0.22	0.11	-0.39
Book Value Growth (%)	-63.09	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.31	-0.02	-0.03	-0.03	-0.09
Price / Book Value	0.59	0.39	0.02	0.02	0.01	0.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.93	-0.18	0.32	1.19	1.66	1.57
Close Price ($)	3.85	5.47	10.70	22.40	26.00	98.00
High Price ($)	7.20	12.60	31.20	40.60	103.20	861.40
Low Price ($)	3.75	4.41	9.50	16.80	23.60	79.20
Market Cap ($ Cr)	7.51	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.87	0.44	0.18	0.13	0.10
Short term debt to equity ratio	0.24	0.11	0.04	0.02	0.01	0.01
Current Ratio	2.61	3.59	3.20	5.17	7.47	8.87
Quick Ratio	2.61	--	3.20	--	7.51	8.88
Interest Coverage	--	--	--	--	-39.63	-16.99

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	12.64	15.15	16.51	13.96	15.87
Asset Turnover	0.07	0.10	0.06	0.04	0.02	0.01
Receivable days	--	50.74	58.54	48.69	31.88	30.73
Inventory Days	--	0.00	0.00	-4.75	-2.50	-0.51
Payable days	--	361.33	376.30	19.53	17.90	12.48
Cash Conversion Cycle	--	-310.59	-317.76	24.42	11.48	17.73

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.